CHS Dream of a Cure Research Grants
The CHS Dream of a Cure Research Grants fund research by the Canadian Hemophilia Society to advance understanding and treatment of inherited bleeding disorders through basic and translational science.
Browse similar grants
Funder: Canadian Hemophilia Society
Due Dates: November 27, 2026: Application deadline
Funding Amounts: Up to $75,000 per year per project; maximum $150,000 total over 2–3 years
Summary: Supports basic and translational research advancing understanding and treatment of inherited bleeding disorders.
Key Information: Only Canadian citizens/permanent residents affiliated with Canadian universities or not-for-profits are eligible.
Description
The CHS Dream of a Cure Research Grants, administered by the Canadian Hemophilia Society (now Bleeding Disorders Canada), fund basic and translational research projects focused on inherited bleeding disorders such as hemophilia A and B, von Willebrand disease, rare factor deficiencies, and platelet function disorders. The program aims to deepen scientific understanding of these conditions and foster the development of improved therapies and potential cures, ultimately enhancing the health and quality of life for affected individuals. Funding is provided for projects that contribute meaningful insights into disease mechanisms, pathophysiology, and therapeutic strategies.
